Neovasc Announces Positive Two-Year Follow-up Safety and Efficacy Data for the Neovasc Reducer(TM) in a Peer Reviewed Article in the International Journal of Cardiology

Stock Information for Neovasc Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Neovasc Inc.

Shockwave Medical Completes Acquisition of Neovasc
Neovasc Announces Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Corporate Update
Neovasc Shareholders Approve Acquisition by Shockwave Medical
Neovasc Announces German Reimbursement Renewal
IIROC Trade Resumption - NVCN
IIROC Trading Halt - NVCN
Shockwave Medical to Acquire Neovasc
Shockwave Medical Announces Agreement to Acquire Neovasc

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.